日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

利用表观基因组调控因子靶向下调MYC转录,在肝细胞癌模型中显示出抗肿瘤活性。

William Senapedis ,Kayleigh M Gallagher ,Elmer Figueroa ,Jeremiah D Farelli ,Robert Lyng ,J Graeme Hodgson ,Charles W O'Donnell ,Joseph V Newman ,Madison Pacaro ,Stephen K Siecinski ,Justin Chen ,Thomas G McCauley

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers

PAK4 抑制剂 KPT9274 在 KRASG12C 突变型胰腺癌和肺癌临床前模型中增强了 KRASG12C 抑制剂的抗癌功效

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md Hafiz Uddin, Sahar F Bannoura, Yousef Mzannar, Ibrahim Azar, Eliza W Beal, Miguel E Tobon, Steve H Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony F Shields, Moh

PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus

PAK4-NAMPT 双重抑制增强胰腺神经内分泌肿瘤对依维莫司的敏感性

Gabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, Amro Aboukameel, Yiwei Li, Steve H Kim, Rafic Beydoun, Gregory Dyson, Erkan Baloglu, William T Senapedis, Yosef Landesman, Kay-Uwe Wagner, Nerissa T Viola, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi

PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma

PAK4 和 NAMPT 作为弥漫性大 B 细胞淋巴瘤、滤泡性淋巴瘤和套细胞淋巴瘤的新型治疗靶点

Husain Yar Khan, Md Hafiz Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu, Ramzi M Mohammad, Jeffrey Zonder, Asfar S Azmi

PAK4 inhibition improves PD-1 blockade immunotherapy

PAK4 抑制可改善 PD-1 阻断免疫疗法

Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, Jesse M Zaretsky, Theodore S Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J Quist, Alejandro J Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoñ

Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney Cancer

PAK4/NAMPT抑制剂和程序性细胞死亡蛋白-1抗体在肾癌中的抗癌活性

Josephine F Trott ,Omran Abu Aboud ,Bridget McLaughlin ,Katie L Anderson ,Jaime F Modiano ,Kyoungmi Kim ,Kuang-Yu Jen ,William Senapedis ,Hua Chang ,Yosef Landesman ,Erkan Baloglu ,Roberto Pili ,Robert H Weiss

Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia

双重 PAK4-NAMPT 抑制影响华氏巨球蛋白血症的生长和存活,并增加其对 DNA 损伤剂的敏感性。

Na Li ,Michael A Lopez ,Maria Linares ,Subodh Kumar ,Stefania Oliva ,Joaquin Martinez-Lopez ,Lian Xu ,Yan Xu ,Tommaso Perini ,William Senapedis ,Erkan Baloglu ,Masood A Shammas ,Zachary Hunter ,Kenneth C Anderson ,Steven P Treon ,Nikhil C Munshi ,Mariateresa Fulciniti

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer

靶向核输出蛋白XPO1/CRM1治疗胃癌

Sexton, Rachel; Mahdi, Zaid; Chaudhury, Rahman; Beydoun, Rafic; Aboukameel, Amro; Khan, Husain Y; Baloglu, Erkan; Senapedis, William; Landesman, Yosef; Tesfaye, Anteneh; Kim, Steve; Philip, Philip A; Azmi, Asfar S

PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors

PAK4-NAMPT 双重抑制作为治疗耐药性胰腺神经内分泌肿瘤的新策略

Gabriel Mpilla, Amro Aboukameel, Irfana Muqbil, Steve Kim, Rafic Beydoun, Philip A Philip, Ramzi M Mohammad, Mandana Kamgar, Vinod Shidham, William Senapedis, Erkan Baloglu, Jing Li, Gregory Dyson, Yue Xue, Bassel El-Rayes, Asfar S Azmi

Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes

利用大规模 CRISPR-Cas 诱变扫描对必需基因进行小分子靶标识别

Jasper Edgar Neggers, Bert Kwanten, Tim Dierckx, Hiroki Noguchi, Arnout Voet, Lotte Bral, Kristien Minner, Bob Massant, Nicolas Kint, Michel Delforge, Thomas Vercruysse, Erkan Baloglu, William Senapedis, Maarten Jacquemyn, Dirk Daelemans